Fan, D., Liu, H., Zhang, Z., Su, M., Yuan, Z., Lin, Y., . . . Zhang, X. (2021). Resveratrol and Angiogenin-2 Combined With PEGDA/TCS Hydrogel for the Targeted Therapy of Hypoxic Bone Defects via Activation of the Autophagy Pathway. Front Pharmacol.

Fan, Dehui, Hengping Liu, Zhenning Zhang, Meiyi Su, Zhixian Yuan, Ying Lin, Shuquan Yang, Wenqiang Li, a Xintao Zhang. "Resveratrol and Angiogenin-2 Combined With PEGDA/TCS Hydrogel for the Targeted Therapy of Hypoxic Bone Defects Via Activation of the Autophagy Pathway." Front Pharmacol 2021.

Fan, Dehui, et al. "Resveratrol and Angiogenin-2 Combined With PEGDA/TCS Hydrogel for the Targeted Therapy of Hypoxic Bone Defects Via Activation of the Autophagy Pathway." Front Pharmacol 2021.